查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1618721

肌紅蛋白市場：按類型、檢測方法和最終用戶分類 - 2025-2030 年全球預測

Myoglobin Market by Type (Animal, Human), Detection Method (Enzyme-Linked Immunosorbent Assay, Immunohistochemistry, Mass Spectrometry), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年肌紅蛋白市場價值為9,741萬美元，預計2024年將達到1,0107萬美元，複合年成長率為3.91%，預計到2030年將達到12,749萬美元。

肌紅蛋白是一種含血紅素的蛋白質，主要因其在肌肉組織中運輸和儲存氧氣的作用而被認可。它在醫學診斷和研究中極為重要，特別是因為它可以及早發現肌肉損傷和心肌梗塞等疾病。對肌紅蛋白的需求是因為它的高敏感性和在肌肉損傷後快速釋放到血液中，這使得它在臨床環境中對於及時診斷非常有價值。其應用不僅限於醫學，還用於科學研究、監測運動員的運動醫學以及食品工業中的肉類品質評估。最終用途範圍包括醫院、診斷實驗室、研究機構、食品加工公司等。

主要市場統計
基準年[2023] 9741萬美元
預測年份 [2024] 10107萬美元
預測年份 [2030] 1.2749億美元
複合年成長率（%） 3.91%

市場洞察表明，心血管疾病盛行率的增加和健康意識的提高是肌紅蛋白市場的主要成長動力。生物技術應用的擴大和研發投資的增加進一步推動了市場的擴張。關鍵機會存在於就地檢驗解決方案的進步和新型診斷分析的開發中，特別是在醫療基礎設施投資不斷增加的新興市場。然而，來自替代生物標記的競爭、監管障礙和檢測成本上升等挑戰可能會阻礙市場成長。由於技術障礙和測試結果的可變性，它們還面臨限制，並且需要在檢測靈敏度和特異性方面進行創新以提高診斷準確性。

需要創新的領域包括開發具有成本效益的快速診斷設備、將人工智慧整合到診斷中進行預測分析，以及透過肌紅蛋白變體的生物工程來提高食品行業的肉類品質等。個人化醫療和精準診斷的研究進展預示著進一步的成長。市場的本質是動態的，由技術進步驅動，創新對於保持競爭優勢至關重要。鼓勵相關人員投資強力的研究合作並使其應用組合多樣化，以有效克服挑戰並利用新機會。

市場動態：揭示快速發展的肌紅蛋白市場的關鍵市場見解

供給和需求的動態交互作用正在改變肌紅蛋白市場。了解這些不斷變化的市場動態可以幫助組織做出明智的投資決策、改善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 心血管疾病患者數量的增加以及對有效診斷和治療解決方案的需求
    • 擴大生物技術研究的投資和夥伴關係
  • 市場限制因素
    • 與肌紅蛋白相關的嚴格監管要求
  • 市場機會
    • 在臨床測試和實驗室中廣泛採用
    • 肉類產業顏色參數控制的新用途
  • 市場問題
    • 與肌紅蛋白萃取相關的複雜性

波特的五力：駕馭肌紅蛋白市場的策略工具

波特的五力框架是了解肌紅蛋白市場競爭格局的關鍵工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解肌紅蛋白市場的外部影響

外部宏觀環境因素在塑造肌紅蛋白市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解肌紅蛋白市場的競爭格局

肌紅蛋白市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：肌紅蛋白市場供應商的績效評估

FPNV定位矩陣是評估肌紅蛋白市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製肌紅蛋白市場的成功之路

對於想要加強在全球市場的影響力的公司來說，肌紅蛋白市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開發：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、未開發地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 心血管疾病的增加以及對有效診斷和治療解決方案的需求
      • 擴大生物技術研究的投資和合作夥伴關係
    • 抑制因素
      • 與肌紅蛋白相關的嚴格監管要求
    • 機會
      • 在臨床測試和實驗室中廣泛採用
      • 控制肉品產業顏色參數的新應用
    • 任務
      • 與肌紅蛋白萃取相關的複雜性
  • 市場區隔分析
    • 類型：利用動物性肌紅蛋白進行研究和創新，以滿足未滿足的患者需求
    • 最終用戶：在診斷實驗室中更多地使用肌紅蛋白來識別與肌肉相關的損傷
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章肌紅蛋白市場：依類型

  • 介紹
  • 動物
  • 人類

第7章 肌紅蛋白市場：依檢測方法

  • 介紹
  • 酵素免疫分析法
  • 免疫組織化學
  • 質譜分析
  • 蛋白質印跡法

第 8 章 肌紅蛋白市場：依最終用戶分類

  • 介紹
  • 診斷實驗室
  • 醫院/診所
  • 製藥和生物技術公司
  • 研究所

第 9 章美洲肌紅蛋白市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太肌紅蛋白市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的肌紅蛋白市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • CytoSorbents 獲得 TFDA核准在中國銷售 CytoSorb
    • 比利時Start-UpsPaleo 使用精密發酵技術生產酵母肌紅蛋白
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • BBI Solutions
  • Bio Rad Laboratories Inc.
  • Bio SB, Inc.
  • bioMerieux SA
  • Boditech Med Inc.
  • DiaSorin SpA
  • DiaSys Diagnostic Systems GmbH
  • F. Hoffmann-La Roche AG
  • GenScript
  • Horiba, Ltd.
  • Leica Biosystems Nussloch GmbH
  • Merck KGaA
  • OriGene Technologies, Inc.
  • PerkinElmer Inc.
  • Randox Laboratories Ltd.
  • Scripps Laboratories Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation
Product Code: MRR-62667ADF95CC

The Myoglobin Market was valued at USD 97.41 million in 2023, expected to reach USD 101.07 million in 2024, and is projected to grow at a CAGR of 3.91%, to USD 127.49 million by 2030.

Myoglobin is a heme-containing protein primarily recognized for its role in transporting and storing oxygen in muscle tissues. It is pivotal in medical diagnostics and research, particularly for its early detection capabilities of muscle injury and conditions such as myocardial infarction. The necessity of myoglobin stems from its high sensitivity and rapid release into the bloodstream following muscle damage, making it invaluable in clinical settings for timely diagnosis. Its applications extend beyond healthcare, being utilized in scientific research, sports medicine for monitoring athletes, and the food industry for meat quality assessment. The end-use scope includes hospitals, diagnostic laboratories, research institutes, and food processing companies.

KEY MARKET STATISTICS
Base Year [2023] USD 97.41 million
Estimated Year [2024] USD 101.07 million
Forecast Year [2030] USD 127.49 million
CAGR (%) 3.91%

Market insights reveal that the growing prevalence of cardiovascular diseases and increasing health awareness are significant growth drivers for the myoglobin market. The expanding applications in biotechnology and increasing investments in research and development further fuel market expansion. Key opportunities exist in advancing point-of-care testing solutions and developing novel diagnostic assays, especially in emerging markets with rising healthcare infrastructure investments. However, challenges such as competition from alternative biomarkers, regulatory hurdles, and high costs of testing can impede market growth. The market also faces limitations from technological barriers and variability in test results, which demand innovations in assay sensitivity and specificity to enhance diagnostic accuracy.

Areas ripe for innovation include developing cost-effective and faster diagnostic devices, integrating artificial intelligence for predictive analytics in diagnostics, and enhancing the bioengineering of myoglobin variants for improved meat quality in the food industry. Research advancements in personalized medicine and precision diagnostics present further growth avenues. The market's nature is dynamic, driven by technological advancements, with innovation being crucial for maintaining competitive advantage. Stakeholders are recommended to invest in robust research collaborations and diversify application portfolios to navigate challenges effectively and leverage emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Myoglobin Market

The Myoglobin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing cases of cardiovascular diseases and the need for effective diagnostic and therapeutic solutions
    • Growing investments and partnerships in biotechnological research
  • Market Restraints
    • Strict regulatory requirements associated with the myoglobin
  • Market Opportunities
    • Significant adoption in clinical trials and research laboratories
    • Emerging usage in meat industries to control color parameter
  • Market Challenges
    • Complexities associated with the extraction of myoglobin

Porter's Five Forces: A Strategic Tool for Navigating the Myoglobin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Myoglobin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Myoglobin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Myoglobin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Myoglobin Market

A detailed market share analysis in the Myoglobin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Myoglobin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Myoglobin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Myoglobin Market

A strategic analysis of the Myoglobin Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Myoglobin Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, BBI Solutions, Bio Rad Laboratories Inc., Bio SB, Inc., bioMerieux S.A., Boditech Med Inc., DiaSorin S.p.A, DiaSys Diagnostic Systems GmbH, F. Hoffmann-La Roche AG, GenScript, Horiba, Ltd., Leica Biosystems Nussloch GmbH, Merck KGaA, OriGene Technologies, Inc., PerkinElmer Inc., Randox Laboratories Ltd., Scripps Laboratories Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., and Tosoh Corporation.

Market Segmentation & Coverage

This research report categorizes the Myoglobin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Animal and Human.
  • Based on Detection Method, market is studied across Enzyme-Linked Immunosorbent Assay, Immunohistochemistry, Mass Spectrometry, and Western Blotting.
  • Based on End-User, market is studied across Diagnostic Laboratories, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing cases of cardiovascular diseases and the need for effective diagnostic and therapeutic solutions
      • 5.1.1.2. Growing investments and partnerships in biotechnological research
    • 5.1.2. Restraints
      • 5.1.2.1. Strict regulatory requirements associated with the myoglobin
    • 5.1.3. Opportunities
      • 5.1.3.1. Significant adoption in clinical trials and research laboratories
      • 5.1.3.2. Emerging usage in meat industries to control color parameter
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities associated with the extraction of myoglobin
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Utilization of animal-based myoglobin in research and innovation to cater to unmet needs of patients
    • 5.2.2. End-User: Increasing usage of myoglobin in diagnostic laboratories for identification of muscle-related injuries
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Myoglobin Market, by Type

  • 6.1. Introduction
  • 6.2. Animal
  • 6.3. Human

7. Myoglobin Market, by Detection Method

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Immunohistochemistry
  • 7.4. Mass Spectrometry
  • 7.5. Western Blotting

8. Myoglobin Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic Laboratories
  • 8.3. Hospitals & Clinics
  • 8.4. Pharmaceutical & Biotechnology Companies
  • 8.5. Research Institutes

9. Americas Myoglobin Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Myoglobin Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Myoglobin Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. CytoSorbents receives TFDA approval to distribute CytoSorb in China
    • 12.3.2. Belgian startup Paleo leverages precision fermentation to produce yeast-based myoglobin
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. BBI Solutions
  • 3. Bio Rad Laboratories Inc.
  • 4. Bio SB, Inc.
  • 5. bioMerieux S.A.
  • 6. Boditech Med Inc.
  • 7. DiaSorin S.p.A
  • 8. DiaSys Diagnostic Systems GmbH
  • 9. F. Hoffmann-La Roche AG
  • 10. GenScript
  • 11. Horiba, Ltd.
  • 12. Leica Biosystems Nussloch GmbH
  • 13. Merck KGaA
  • 14. OriGene Technologies, Inc.
  • 15. PerkinElmer Inc.
  • 16. Randox Laboratories Ltd.
  • 17. Scripps Laboratories Inc.
  • 18. Siemens Healthineers AG
  • 19. Thermo Fisher Scientific Inc.
  • 20. Tosoh Corporation

LIST OF FIGURES

  • FIGURE 1. MYOGLOBIN MARKET RESEARCH PROCESS
  • FIGURE 2. MYOGLOBIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MYOGLOBIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MYOGLOBIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MYOGLOBIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MYOGLOBIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MYOGLOBIN MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MYOGLOBIN MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MYOGLOBIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MYOGLOBIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MYOGLOBIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MYOGLOBIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MYOGLOBIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MYOGLOBIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MYOGLOBIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MYOGLOBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MYOGLOBIN MARKET DYNAMICS
  • TABLE 7. GLOBAL MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MYOGLOBIN MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MYOGLOBIN MARKET SIZE, BY HUMAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MYOGLOBIN MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MYOGLOBIN MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MYOGLOBIN MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MYOGLOBIN MARKET SIZE, BY WESTERN BLOTTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MYOGLOBIN MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MYOGLOBIN MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MYOGLOBIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MYOGLOBIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MYOGLOBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES MYOGLOBIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC MYOGLOBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA MYOGLOBIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM MYOGLOBIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM MYOGLOBIN MARKET SIZE, BY DETECTION METHOD, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM MYOGLOBIN MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. MYOGLOBIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. MYOGLOBIN MARKET, FPNV POSITIONING MATRIX, 2023